Clinical Trial Update: OEA for Targeting Lipid Metabolism in GWI [NA]

View source ↗

Summary

A completed clinical trial evaluating oleoylethanolamide (OEA) for targeting lipid metabolism in Gulf War Illness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gulf War Illness

Drugs mentioned

• Oleoylethanolamide (OEA) (oleoylethanolamide)

Snippet

Sponsor: Roskamp Institute Inc. | Conditions: Gulf War Illness | NA | Status: COMPLETED